|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Penicillins & their derivs. with a penicillanic acid structure; salts there ... | $36,891,449 | $51,896,812 | $41,883,979 | $45,317,188 | $34,439,372 | $37,948,392 | $49,313,514 |
| Streptomycins & their derivs.; salts thereof | $573,610 | $1,584,501 | $1,938,006 | $3,134,113 | $2,730,111 | $3,671,570 | $5,088,443 |
| Tetracyclines & their derivs.; salts thereof | $19,542,551 | $20,643,717 | $20,623,564 | $18,403,891 | $19,911,628 | $18,783,327 | $19,699,804 |
| Chloramphenicol & its derivs.; salts thereof | $15,222,436 | $26,606,313 | $18,896,927 | $20,020,310 | $15,747,758 | $10,195,565 | $3,232,282 |
| Erythromycin & its derivs.; salts thereof | $72,305,947 | $75,016,469 | $4,772,270 | $6,891,513 | $6,165,304 | $8,990,707 | $17,278,723 |
| Antibiotics & their derivs. (excl. of 2941.10-2941.50); salts thereof | $221,191,917 | $209,272,193 | $269,809,633 | $289,113,493 | $366,258,204 | $439,610,184 | $665,795,753 |
| Total | $365,727,910 | $385,020,005 | $357,924,379 | $382,880,508 | $445,252,377 | $519,199,745 | $760,408,519 |
|
|
